Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Low-Dose vs. High-Dose Cisplatin: Lessons Learned From 59 Chemoradiotherapy Trials in Head and Neck Cancer.

Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V, Adelstein D, Van Gestel D, Vermorken JB.

Front Oncol. 2019 Feb 21;9:86. doi: 10.3389/fonc.2019.00086. eCollection 2019. Review.

2.

Case Report: Primary Orbital Squamous Cell Carcinoma.

Blandford AD, Bellerive C, Tom M, Koyfman S, Adelstein DJ, Plesec TP, Perry JD, Singh AD.

Ocul Oncol Pathol. 2019 Jan;5(1):60-65. doi: 10.1159/000490060. Epub 2018 Jun 29.

PMID:
30675479
3.

Data Set for the Reporting of Carcinomas of the Nasopharynx and Oropharynx: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting.

Lewis JS Jr, Adelstein DJ, Agaimy A, Carlson DL, Faquin WC, Helliwell T, Hille J, Ng T, Nicholls JM, O'Sullivan B, Thompson LDR.

Arch Pathol Lab Med. 2018 Nov 30. doi: 10.5858/arpa.2018-0405-SA. [Epub ahead of print]

PMID:
30500294
4.

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT.

Lancet. 2019 Jan 5;393(10166):40-50. doi: 10.1016/S0140-6736(18)32779-X. Epub 2018 Nov 15.

PMID:
30449625
5.

Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases.

Varra V, Woody NM, Reddy C, Joshi NP, Geiger J, Adelstein DJ, Burkey BB, Scharpf J, Prendes B, Lamarre ED, Lorenz R, Gastman B, Manyam BV, Koyfman SA.

Anticancer Res. 2018 Oct;38(10):5825-5830. doi: 10.21873/anticanres.12923.

PMID:
30275206
6.

Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and Toxicity.

Juloori A, Koyfman SA, Geiger JL, Joshi NP, Woody NM, Burkey BB, Scharpf J, Lamarre EL, Prendes B, Adelstein DJ, Greskovich JF, Keller L.

Anticancer Res. 2018 Jun;38(6):3543-3549. doi: 10.21873/anticanres.12626.

PMID:
29848708
7.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
8.

Response to ASTRO consensus guideline for oropharyngeal cancer: In Regard to Walker et al.

Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EE, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A.

Pract Radiat Oncol. 2018 May - Jun;8(3):e185-e186. doi: 10.1016/j.prro.2017.08.002. Epub 2017 Aug 5. No abstract available.

PMID:
29724403
9.

Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al.

Molenaar RJ, Sidana S, Radivoyevitch T, Gerds AT, Carraway HE, Kalaycio M, Nazha A, Adelstein DJ, Nasr C, Maciejewski JP, Majhail NS, Sekeres MA, Mukherjee S.

J Clin Oncol. 2018 Jun 20;36(18):1889-1892. doi: 10.1200/JCO.2018.78.4074. Epub 2018 May 3. No abstract available.

PMID:
29723096
10.

Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.

Xiao R, Ward MC, Yang K, Adelstein DJ, Koyfman SA, Prendes BL, Burkey BB.

Cancer. 2018 Apr 1;124(7):1400-1414. doi: 10.1002/cncr.31213. Epub 2018 Jan 9.

PMID:
29315499
11.

Altered fractionation radiotherapy combined with concurrent low-dose or high-dose cisplatin in head and neck cancer: A systematic review of literature and meta-analysis.

Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V, Adelstein D, Vermorken JB.

Oral Oncol. 2018 Jan;76:52-60. doi: 10.1016/j.oraloncology.2017.11.025. Epub 2017 Dec 8. Review.

PMID:
29290286
12.

Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer.

Molenaar RJ, Sidana S, Radivoyevitch T, Advani AS, Gerds AT, Carraway HE, Angelini D, Kalaycio M, Nazha A, Adelstein DJ, Nasr C, Maciejewski JP, Majhail NS, Sekeres MA, Mukherjee S.

J Clin Oncol. 2018 Jun 20;36(18):1831-1839. doi: 10.1200/JCO.2017.75.0232. Epub 2017 Dec 18.

PMID:
29252123
13.

Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Forastiere AA, Ismaila N, Lewin JS, Nathan CA, Adelstein DJ, Eisbruch A, Fass G, Fisher SG, Laurie SA, Le QT, O'Malley B, Mendenhall WM, Patel S, Pfister DG, Provenzano AF, Weber R, Weinstein GS, Wolf GT.

J Clin Oncol. 2018 Apr 10;36(11):1143-1169. doi: 10.1200/JCO.2017.75.7385. Epub 2017 Nov 27.

PMID:
29172863
14.

Cost-effectiveness of nivolumab for recurrent or metastatic head and neck cancer☆.

Ward MC, Shah C, Adelstein DJ, Geiger JL, Miller JA, Koyfman SA, Singer ME.

Oral Oncol. 2017 Nov;74:49-55. doi: 10.1016/j.oraloncology.2017.09.017. Epub 2017 Sep 23.

PMID:
29103751
15.

A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.

Ross RB, Koyfman SA, Reddy CA, Houston N, Geiger JL, Woody NM, Joshi NP, Greskovich JF Jr, Burkey BB, Scharpf J, Lamarre ED, Prendes B, Lorenz RR, Adelstein DJ, Ward MC.

Laryngoscope. 2018 Jun;128(6):1379-1385. doi: 10.1002/lary.26965. Epub 2017 Oct 31.

PMID:
29086413
16.

Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.

Quon H, Vapiwala N, Forastiere A, Kennedy EB, Adelstein DJ, Boykin H, Califano JA, Holsinger FC, Nussenbaum B, Rosenthal DI, Siu LL, Waldron JN.

J Clin Oncol. 2017 Dec 20;35(36):4078-4090. doi: 10.1200/JCO.2017.73.8633. Epub 2017 Oct 24.

PMID:
29064744
17.

Elucidation of salvage laryngectomy pathologic and clinical variables to guide further treatment intensification investigation.

Scharpf J, Ward M, Adelstein D, Koyfman S, Li M.

Laryngoscope. 2018 Apr;128(4):823-830. doi: 10.1002/lary.26782. Epub 2017 Sep 11.

PMID:
28891087
18.

Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.

Woody NM, Ward MC, Koyfman SA, Reddy CA, Geiger J, Joshi N, Burkey B, Scharpf J, Lamarre E, Prendes B, Adelstein DJ.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):784-792. doi: 10.1016/j.ijrobp.2017.03.019. Epub 2017 Mar 18.

PMID:
28602410
19.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
20.

Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.

Szturz P, Wouters K, Kiyota N, Tahara M, Prabhash K, Noronha V, Castro A, Licitra L, Adelstein D, Vermorken JB.

Oncologist. 2017 Sep;22(9):1056-1066. doi: 10.1634/theoncologist.2017-0015. Epub 2017 May 22. Review.

21.

Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline.

Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EEW, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A.

Pract Radiat Oncol. 2017 Jul - Aug;7(4):246-253. doi: 10.1016/j.prro.2017.02.002. Epub 2017 Apr 17.

PMID:
28428019
22.

Predictors of distant metastasis in human papillomavirus-associated oropharyngeal cancer.

Weller MA, Ward MC, Berriochoa C, Reddy CA, Trosman S, Greskovich JF, Nwizu TI, Burkey BB, Adelstein DJ, Koyfman SA.

Head Neck. 2017 May;39(5):940-946. doi: 10.1002/hed.24711. Epub 2017 Feb 11.

PMID:
28188964
23.

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.

Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, Le QT, Raben D, Strome SE, Lynn J, Malik S.

Cancer. 2017 Apr 1;123(7):1259-1271. doi: 10.1002/cncr.30449. Epub 2016 Dec 1.

24.

Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative Outcomes.

McNamara MJ, Adelstein DJ, Allende DS, Bodmann JW, Ives DI, Murthy SC, Raymond D, Raja S, Rodriguez CP, Sohal D, Stephans KL, Videtic GMM, Rybicki LA.

J Gastrointest Cancer. 2017 Jun;48(2):181-189. doi: 10.1007/s12029-016-9881-x.

PMID:
27734205
25.

Importance of residual primary cancer after induction therapy for esophageal adenocarcinoma.

Raja S, Rice TW, Ehrlinger J, Goldblum JR, Rybicki LA, Murthy SC, Adelstein D, Videtic G, McNamara MP, Blackstone EH.

J Thorac Cardiovasc Surg. 2016 Sep;152(3):756-761.e5. doi: 10.1016/j.jtcvs.2016.05.007. Epub 2016 May 10.

26.

Use of systemic therapy with definitive radiotherapy for elderly patients with head and neck cancer: A National Cancer Data Base analysis.

Ward MC, Reddy CA, Adelstein DJ, Koyfman SA.

Cancer. 2016 Nov 15;122(22):3472-3483. doi: 10.1002/cncr.30214. Epub 2016 Aug 9.

27.

Modern Image-Guided Intensity-Modulated Radiotherapy for Oropharynx Cancer and Severe Late Toxic Effects: Implications for Clinical Trial Design.

Ward MC, Ross RB, Koyfman SA, Lorenz R, Lamarre ED, Scharpf J, Burkey BB, Joshi NP, Woody NM, Prendes B, Houston N, Reddy CA, Greskovich JF, Adelstein DJ.

JAMA Otolaryngol Head Neck Surg. 2016 Dec 1;142(12):1164-1170. doi: 10.1001/jamaoto.2016.1876.

PMID:
27438230
28.

Impaired vocal cord mobility in T2N0 glottic carcinoma: Suboptimal local control with Radiation alone.

Bhateja P, Ward MC, Hunter GH, Greskovich JF, Reddy CA, Nwizu TI, Lamarre E, Burkey BB, Adelstein DJ, Koyfman SA.

Head Neck. 2016 Dec;38(12):1832-1836. doi: 10.1002/hed.24520. Epub 2016 Jun 14.

PMID:
27299502
29.

Severe late dysphagia and cause of death after concurrent chemoradiation for larynx cancer in patients eligible for RTOG 91-11.

Ward MC, Adelstein DJ, Bhateja P, Nwizu TI, Scharpf J, Houston N, Lamarre ED, Lorenz R, Burkey BB, Greskovich JF, Koyfman SA.

Oral Oncol. 2016 Jun;57:21-6. doi: 10.1016/j.oraloncology.2016.03.014. Epub 2016 Apr 1.

PMID:
27208840
30.

The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimen.

McNamara MJ, Rybicki LA, Sohal D, Allende DS, Videtic GM, Rodriguez CP, Stephans KL, Murthy SC, Raja S, Raymond D, Ives DI, Bodmann JW, Adelstein DJ.

J Gastrointest Oncol. 2016 Apr;7(2):196-205. doi: 10.3978/j.issn.2078-6891.2015.097.

31.

Split-Course Accelerated Hypofractionated Radiotherapy (SCAHRT): A Safe and Effective Option for Head and Neck Cancer in the Elderly or Infirm.

Bledsoe TJ, Noble AR, Reddy CA, Burkey BB, Greskovich JF, Nwizu T, Adelstein DJ, Saxton JP, Koyfman SA.

Anticancer Res. 2016 Mar;36(3):933-9.

PMID:
26976981
32.

Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.

O'Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, Lee N, Riaz N, Pei X, Koyfman SA, Adelstein D, Burkey BB, Friborg J, Kristensen CA, Gothelf AB, Hoebers F, Kremer B, Speel EJ, Bowles DW, Raben D, Karam SD, Yu E, Xu W.

Lancet Oncol. 2016 Apr;17(4):440-451. doi: 10.1016/S1470-2045(15)00560-4. Epub 2016 Feb 27.

PMID:
26936027
33.

Risk Factors Associated with Disease Recurrence in Patients with Stage III/IV Squamous Cell Carcinoma of the Oral Cavity Treated with Surgery and Postoperative Radiotherapy.

Noble AR, Greskovich JF, Han J, Reddy CA, Nwizu TI, Khan MF, Scharpf J, Adelstein DJ, Burkey BB, Koyfman SA.

Anticancer Res. 2016 Feb;36(2):785-92.

PMID:
26851040
34.

Regional control is preserved after dose de-escalated radiotherapy to involved lymph nodes in HPV positive oropharyngeal cancer.

Woody NM, Koyfman SA, Xia P, Yu N, Shang Q, Adelstein DJ, Scharpf J, Burkey B, Nwizu T, Saxton J, Greskovich JF Jr.

Oral Oncol. 2016 Feb;53:91-6. doi: 10.1016/j.oraloncology.2015.11.004. Epub 2015 Dec 23.

PMID:
26711089
35.

Prospective Clinical Study of Precision Oncology in Solid Tumors.

Sohal DP, Rini BI, Khorana AA, Dreicer R, Abraham J, Procop GW, Saunthararajah Y, Pennell NA, Stevenson JP, Pelley R, Estfan B, Shepard D, Funchain P, Elson P, Adelstein DJ, Bolwell BJ.

J Natl Cancer Inst. 2015 Nov 9;108(3). pii: djv332. doi: 10.1093/jnci/djv332.

PMID:
26553780
36.

Pharmacotherapy of head and neck cancer.

Nwizu T, Adelstein D.

Expert Opin Pharmacother. 2015;16(16):2409-22. doi: 10.1517/14656566.2015.1085507. Epub 2015 Oct 29. Review.

PMID:
26513647
37.

Impact of feeding tube choice on severe late dysphagia after definitive chemoradiotherapy for human papillomavirus-negative head and neck cancer.

Ward MC, Bhateja P, Nwizu T, Kmiecik J, Reddy CA, Scharpf J, Lamarre ED, Burkey BB, Greskovich JF, Adelstein DJ, Koyfman SA.

Head Neck. 2016 Apr;38 Suppl 1:E1054-60. doi: 10.1002/hed.24157. Epub 2015 Sep 2.

PMID:
26045168
38.

Oncologic and Functional Outcomes of Surgical and Nonsurgical Treatment of Advanced Squamous Cell Carcinoma of the Supraglottic Larynx.

Elegbede AI, Rybicki LA, Adelstein DJ, Kaltenbach JA, Lorenz RR, Scharpf J, Burkey BB.

JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1111-7. doi: 10.1001/jamaoto.2015.0663.

PMID:
25950990
39.

First Site of Failure Analysis Incompletely Addresses Issues of Late and Unexpected Metastases in p16-Positive Oropharyngeal Cancer.

O'Sullivan B, Adelstein DL, Huang SH, Koyfman SA, Thorstad W, Hope AJ, Lewis JS Jr, Nussenbaum B.

J Clin Oncol. 2015 May 20;33(15):1707-8. doi: 10.1200/JCO.2014.58.2700. Epub 2015 Mar 30. No abstract available.

PMID:
25823739
40.

Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.

Trosman SJ, Koyfman SA, Ward MC, Al-Khudari S, Nwizu T, Greskovich JF, Lamarre ED, Scharpf J, Khan MJ, Lorenz RR, Adelstein DJ, Burkey BB.

JAMA Otolaryngol Head Neck Surg. 2015 May 1;141(5):457-62. doi: 10.1001/jamaoto.2015.136. Erratum in: JAMA Otolaryngol Head Neck Surg. 2015 May 1;141(5):428.

PMID:
25742025
41.

Current status of clinical trials in head and neck cancer 2014.

Liu JC, Ridge JA, Brizel DM, O'Sullivan B, Cohen EW, Mann BS, Adelstein DJ.

Otolaryngol Head Neck Surg. 2015 Mar;152(3):410-7. doi: 10.1177/0194599814566595. Epub 2015 Jan 20. Review.

PMID:
25605695
42.

A phase II trial of induction epirubicin, oxaliplatin, and fluorouracil, followed by surgery and postoperative concurrent cisplatin and fluorouracil chemoradiotherapy in patients with locoregionally advanced adenocarcinoma of the esophagus and gastroesophageal junction.

McNamara MJ, Adelstein DJ, Bodmann JW, Greskovich JF Jr, Ives DI, Mason DP, Murthy SC, Rice TW, Saxton JP, Sohal D, Stephans K, Rodriguez CP, Videtic GM, Rybicki LA.

J Thorac Oncol. 2014 Oct;9(10):1561-7. doi: 10.1097/JTO.0000000000000312.

43.

In squamous cell head and neck cancer: which platinum, how much and how often?

Nwizu T, Adelstein DJ.

Expert Rev Anticancer Ther. 2014 Sep;14(9):1033-9. doi: 10.1586/14737140.2014.924399. Epub 2014 Jul 6. Review.

PMID:
24998393
44.

Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design.

Rodriguez CP, Adelstein DJ, Rybicki LA, Savvides P, Saxton JP, Koyfman SA, Greskovich JF, Yao M, Scharpf J, Lavertu P, Wood BG, Burkey BB, Lorenz RR, Rezaee RP, Zender CA, Ives DI.

Head Neck. 2015 Nov;37(11):1583-9. doi: 10.1002/hed.23794. Epub 2014 Oct 29.

PMID:
24909549
45.

Solitary dural metastasis at presentation in a patient with untreated human papillomavirus-associated squamous cell carcinoma of the oropharynx.

Al-Khudari S, Guo S, Chen Y, Nwizu T, Greskovich JF, Lorenz R, Burkey BB, Adelstein DJ, Koyfman SA.

Head Neck. 2014 Oct;36(10):E103-5. doi: 10.1002/hed.23589. Epub 2014 Mar 20.

PMID:
24375789
46.

Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes.

Bledsoe TJ, Noble AR, Hunter GK, Rybicki LA, Hoschar A, Chute DJ, Saxton JP, Greskovich JF, Adelstein DJ, Koyfman SA.

Radiat Oncol. 2013 Jul 9;8:174. doi: 10.1186/1748-717X-8-174.

47.

Induction chemotherapy meta-analysis in head and neck cancer: right answer, wrong question.

Forastiere AA, Adelstein DJ, Manola J.

J Clin Oncol. 2013 Aug 10;31(23):2844-6. doi: 10.1200/JCO.2013.50.3136. Epub 2013 Jul 8. No abstract available.

PMID:
23835711
48.

Salvage laryngectomy in patients with recurrent laryngeal cancer in the setting of nonoperative treatment failure.

Li M, Lorenz RR, Khan MJ, Burkey BB, Adelstein DJ, Greskovich JF Jr, Koyfman SA, Scharpf J.

Otolaryngol Head Neck Surg. 2013 Aug;149(2):245-51. doi: 10.1177/0194599813486257. Epub 2013 Apr 12.

PMID:
23585149
49.

A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.

Halmos B, Jia Y, Bokar JA, Fu P, Adelstein DJ, Juergens R, Rodal MB, Dowlati A.

Invest New Drugs. 2013 Oct;31(5):1244-50. doi: 10.1007/s10637-013-9945-8. Epub 2013 Apr 4.

PMID:
23553066
50.

Transoral resection of pharyngeal cancer: summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6-7, 2011, Arlington, Virginia.

Adelstein DJ, Ridge JA, Brizel DM, Holsinger FC, Haughey BH, O'Sullivan B, Genden EM, Beitler JJ, Weinstein GS, Quon H, Chepeha DB, Ferris RL, Weber RS, Movsas B, Waldron J, Lowe V, Ramsey S, Manola J, Yueh B, Carey TE, Bekelman JE, Konski AA, Moore E, Forastiere A, Schuller DE, Lynn J, Ullmann CD.

Head Neck. 2012 Dec;34(12):1681-703. doi: 10.1002/hed.23136. Epub 2012 Sep 26.

Supplemental Content

Loading ...
Support Center